Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies.

Literature DB >> 11750834

Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies.

A H Calvert, M J Egorin.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2002 PMID： 11750834 DOI： 10.1016/s0959-8049(01)00340-9

Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Validation of Tikhonov adaptively regularized gamma variate fitting with 24-h plasma clearance in cirrhotic patients with ascites.

Authors: Carl Adam Wesolowski; Lin Ling; Elias Xirouchakis; Maria T Burniston; Richard C Puetter; Paul S Babyn; Ioannis G Giamalis; Andrew K Burroughs
Journal: Eur J Nucl Med Mol Imaging Date: 2011-09-01 Impact factor: 9.236

2. Comparison of two methods for carboplatin dosing in children with retinoblastoma.

Authors: Steven Allen; Matthew W Wilson; Amy Watkins; Catherine Billups; Ibrahim Qaddoumi; Barrett H Haik; Carlos Rodriguez-Galindo
Journal: Pediatr Blood Cancer Date: 2010-07-15 Impact factor: 3.167

3. A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function.

Authors: Anders Viberg; Anders Lannergård; Anders Larsson; Otto Cars; Mats O Karlsson; Marie Sandström
Journal: Br J Clin Pharmacol Date: 2006-09 Impact factor: 4.335

Review 4. Chemotherapy for bladder cancer in patients with impaired renal function.

Authors: Steve Nicholson
Journal: Nat Rev Urol Date: 2011-11-22 Impact factor: 14.432

5. Tikhonov adaptively regularized gamma variate fitting to assess plasma clearance of inert renal markers.

Authors: Carl A Wesolowski; Richard C Puetter; Lin Ling; Paul S Babyn
Journal: J Pharmacokinet Pharmacodyn Date: 2010-09-24 Impact factor: 2.745

6. Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.

Authors: Isamu Okamoto; Nobuyuki Yamamoto; Kaoru Kubota; Yuichiro Ohe; Naoyuki Nogami; Haruyasu Murakami; Hidetoshi Yamaya; Katsuhiro Ono; Kazuhiko Nakagawa
Journal: Invest New Drugs Date: 2011-05-03 Impact factor: 3.850

Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies.

1. Validation of Tikhonov adaptively regularized gamma variate fitting with 24-h plasma clearance in cirrhotic patients with ascites.

2. Comparison of two methods for carboplatin dosing in children with retinoblastoma.

3. A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function.

Review 4. Chemotherapy for bladder cancer in patients with impaired renal function.

5. Tikhonov adaptively regularized gamma variate fitting to assess plasma clearance of inert renal markers.

6. Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.

Review 7. Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy.

8. Current treatment options for clinical stage I seminoma.

Review 9. A systematic review of limited sampling strategies for platinum agents used in cancer chemotherapy.

Review 10. Pharmacological factors influencing anticancer drug selection in the elderly.